Back

Long-term outcomes in patients with dual pathology aortic stenosis and cardiac amyloidosis referred for valve intervention

31 August 2024 (15:00 - 15:50)
Organised by: Logo
Congress Presentation Part of: Cardiac amyloidosis: how to stage and score Infiltrative Myocardial Disease ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Kush Patel

Barts Health NHS Trust, London (United Kingdom of Great Britain & Northern Ireland)

7 More presentations in this session

Presentation thumbnail
Validation of two simple scores to identify increased risk of transthyretin amyloid cardiomyopathy in heart failure with preserved ejection fraction
Doctor M. Llevadot Sesmilo (Badalona, ES)
Abstract Slides Video
Presentation thumbnail
DPD quantification correlates with ECV and disease severity in patients with ATTR-CM
Doctor R. Rettl (Vienna, AT)
Abstract Slides Video
Presentation thumbnail
Prognostic significance of right ventricular dysfunction in patients with TTR amyloidosis
Doctor S. Istratoaie (Cluj Napoca, RO) Professor E. Donal (Rennes, FR)
Abstract Slides Video
Presentation thumbnail
Characterizing the progression of subclinical cardiac amyloidosis through artificial intelligence applied to electrocardiographic images and echocardiograms
Doctor E. Oikonomou (New Haven, US)
Abstract Slides Video
Presentation thumbnail
Prognostic staging system correctly identifies high risk groups in cardiac transthyretin amyloidosis treated with tafamidis
Mr M. Mueller (Berlin, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiac amyloidosis: how to stage and score

The Event

Event poster

ESC Congress 2024

31 August 2024 15:00 CET
You may be interested in
thumbnail
Congress Presentation
Prognostic significance of concomitant transthyretin cardiac amyloidosis and severe aortic stenosis: insights from a systematic review and meta-analysis
thumbnail
Congress Presentation
Diagnose amyloidosis in patients with non-severe aortic stenosis: when? how?
thumbnail
Congress Presentation
Temporal trends and outcomes of heart failure patients between light-chain cardiac amyloidosis and transthyretin cardiac amyloidosis: insights from the national inpatient sample database

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources